Bored Review NM4 - Comprehensive Clinical Guide to Inclusion Body Myositis and Inflammatory Myopathies
Evaluation of Muscle Biopsy and Pathological Inflammation
Initial Pathological Features: Inflammation in muscle biopsies can present with specific facial features, and may involve a lid cone or modula structure during the biopsy process.
Inflammatory Characteristics:
Patient may exhibit necrotic inflammation.
Nana necrotic muscle fiber inflammation is a key finding.
Pathologists may observe cellular invasion within the muscle fibers.
European Neuromuscular Criteria for Inclusion Body Myositis (IBM) Diagnosis
General Diagnostic Framework: The diagnosis follows a step-by-step process involving clinical presentation, mandatory investigations, and supportive features.
Step 1: Clinical Presentation Criteria
Age of Onset: Traditional criteria required the patient to be older than 50 years; however, the new criteria specify an age of 45 years or older.
Duration: The condition is chronic, defined as at least more than one year of progressive muscle weakness.
Creatine Kinase (CK) Levels: Typically, the CK level is less than 15 times () the upper limit of normal ().
Common (Typical) Presentation:
Characterized by "common IBM muscle involvement pattern."
Involves deep finger flexion weakness.
Involves knee extensor weakness.
Uncommon (Atypical) Presentation Criteria:
Age of onset less than 45 years old.
Acute or subacute onset, or less than one year of progressive weakness.
CK levels exceeding 15 times () the upper limit of normal.
Presence of acute pulmonary edema.
Axial weakness.
Isolated dysphagia.
Foot drop.
Facial diplegia.
Proximal limb weakness in the absence of finger flexion weakness and knee extension weakness.
Investigation Requirements for IBM
Mandatory Investigation Findings:
Evidence of endomysial lymphocytes surrounding nonnecrotic muscle fibers.
This may occur with or without cellular invasion.
Specific biopsy finding: nonnecrotic muscle fiber surrounded by inflammation.
Supportive Features for Diagnosis:
Pathology (Mitochondrial Abnormality): Identified via Mitochondrial stain, specifically the Succinate Dehydrogenase () stain, which shows cycloid abnormal findings.
Laboratory Tests: Detection of anti- antibodies ().
Muscle Imaging: Typical appearance on Muscle MRI or diagnostic findings on ultrasound.
Diagnostic Decision Logic for IBM
Category: Definitive IBM (Common Presentation):
Requires a typical presentation (Finger flexion weakness + knee extension weakness) PLUS mandatory investigation findings (nonnecrotic muscle fiber inflammation).
Category: Probable IBM (Typical but Partial):
Requires finger flexion weakness OR knee extension weakness PLUS mandatory investigation findings PLUS at least one supportive investigation finding.
Category: IBM (Uncommon Presentation):
Requires an uncommon clinical presentation PLUS mandatory investigation findings PLUS at least two out of four supportive findings.
Differential Diagnosis and Alternative Diagnosis Indicators
Red Flags for Alternative Diagnoses: Certain factors suggest a diagnosis other than IBM is more likely:
Family History: IBM is usually a sporadic disease. A positive family history of any neuromuscular disease suggests a genetic or alternative condition.
Electromyography (EMG): Findings not consistent with IBM (e.g., lack of denervation). Expected IBM findings include positive shortwave or fibrillation.
Specific Antibodies: Presence of myocyte-specific antibodies such as (Likely referring to anti-Jo-1) or antigens associated with antisynthetase syndrome (e.g., ).
Serum Enzymes and Biomarkers in Myopathy vs. Liver Disease
Liver-Specific Markers: Gamma-glutamyl transferase () is elevated in patients with liver disease but remains normal in patients with myopathies. This makes it a specific marker for liver damage.
Shared Markers: The following enzymes can be elevated in both liver disease and muscle damage (myopathy), making them less specific:
Alanine aminotransferase ().
Aspartate aminotransferase ().
Aldolase.
Lactate dehydrogenase ().
Clinical Application: If a patient has a high liver function test () and high , it indicates liver damage. If is normal despite other elevations, muscle damage should be suspected.
Dermatomyositis Specific Antibodies and Malignancy Risks
Anti- (Transcriptional Intermediary Factor 1-gamma):
Most strongly associated with malignancy (cancer) in adults.
Patients positive for this antibody require maintenance screening for malignancy for at least three years.
In children, it causes severe skin disease, including palmar hyperkeratotic papules and a psoriasis-like syndrome.
Anti-:
Associated with a very benign course.
Higher prevalence in Hispanic populations.
Usually presents with minimal or no muscle weakness.
Anti- (Melanoma Differentiation-Associated Protein 5):
Associated with Interstitial Lung Disease ().
Associated with cardiopulmonary syndrome.
Clinical signs include skin ulcerations and oral restorations/ulcerations.
Anti- (Nuclear Matrix Protein 2):
Seen in pediatric/juvenile dermatomyositis.
Associated with cancer risk, though lower than anti-.
Associated with dysphagia.
Anti- (Small Ubiquitin-like Modifier Activating Enzyme):
Characterized by skin manifestations presenting before the onset of muscle weakness.
Clinical Characterization of Myotonia
Paramyotonia Congenita:
Demonstrable myotonia that worsens with repetition of the eliciting maneuver (paradoxical myotonia).
Worsens significantly in cold environments.
Myotonic Dystrophy (Type 1 and Type 2):
Characterized by the "warm-up" phenomenon.
Myotonia improves with the repetition of the maneuver.
Other Related Conditions: Anderson-Tawil Syndrome and Channel Myotonia possess distinct clinical behaviors regarding repetition.
Questions & Discussion
Question: Which of the following serum enzymes are elevated in patients with liver disease and normal in patients with myopathies? (Options: Alanine aminotransferase, Aldolase, Aspartate aminotransferase, Gamma glutamyl transferase, Lactate dehydrogenase).
Response: Gamma glutamyl transferase (). It is specific to the liver and not for muscle.
Question: Which dermatomyositis specific antibody is most associated with malignancy?
Response: . Patients require at least three years of cancer screening.
Question: Which of the following conditions have demonstrable myotonia that worsen with repetition of the eliciting maneuver?
Response: Baromyotonia (Paramyotonia congenita), due to paradoxical myotonia. Classically, myotonic dystrophy improves with repetition.